NAIROBI, Feb 11 (Reuters) - Kenya is going ahead with its
plan to inoculate its citizens against COVID-19 using a vaccine
developed by AstraZeneca, a senior ministry of health
official said on Thursday, dismissing concerns over its
efficacy.
"We are going to continue with AstraZeneca because we are
doing our own sequencing and we are comfortable to move forward
with it," Mercy Mwangangi, the chief administrative secretary at
the ministry, told Reuters.
(Reporting by Duncan Miriri, Editing by William Maclean)